Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/1995
05/31/1995EP0655063A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension
05/31/1995EP0655058A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/31/1995EP0655056A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
05/31/1995EP0655055A1 Tachykinin antagonists
05/31/1995EP0654994A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
05/31/1995EP0465520B1 Sugar composition comprising soluble fibre
05/31/1995CN1028655C NF-1616-904 oxide of pyrazine and medicine composition contained this compound
05/30/1995US5420339 Alpha-aryl or heteroaryl-substituted amide ester ACAT inhibitors
05/30/1995US5420333 Lignan analogues, methods of preparation thereof and anti-hyperlipemic agents
05/30/1995US5420292 Biphenyl-tetrazole intermediate compounds
05/30/1995US5420287 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
05/30/1995US5420247 Genetic engineering and expression vectors
05/30/1995US5420151 Serotonin antagonists
05/30/1995US5420150 Antidepressants and treatment of anxiety
05/30/1995US5420149 Imidazolyl-substituted phenylacetamides
05/30/1995US5420142 For treatment of cardiovascular conditions which require an increase in contractility of the heart
05/30/1995US5420141 Capable of binding to neurotensin receptor
05/30/1995US5420138 Bicyclic pyridines which are angiotensin II inhibitors
05/30/1995US5420134 Substituted hexahydrobenzo[A]phenanthridines
05/30/1995US5420132 Substituted benzodioxins
05/30/1995US5420129 Treatment of hypertension, ischemia, vasospasms, angina
05/30/1995US5420127 Morpholino-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/30/1995US5420019 Stable bactericidal/permeability-increasing protein muteins
05/30/1995US5419912 Adhesive patch for percutaneous delivery of isosorbide dinitrate
05/30/1995CA2136712A1 Piperazine derivatives
05/30/1995CA1335716C Methods for increasing extracellular adenosine and for stabilizing mast cells
05/26/1995WO1995014095A1 Endothelin-converting enzyme
05/26/1995WO1995014025A1 Piperidinylcamphorsulfonyl oxytocin antagonists
05/26/1995WO1995014017A1 Non-peptide tachykinin receptor antagonists
05/26/1995WO1995014007A1 Phenyl-alkyl imidazoles as h3-receptor antagonists
05/26/1995WO1995014005A1 Diaminocyclobutene-3,4-diones as smooth muscle relaxants
05/26/1995WO1995013830A1 Method for inhibiting angiogenesis using heparinase
05/26/1995WO1995013820A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
05/26/1995WO1995013818A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
05/26/1995WO1995013803A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995WO1995013800A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
05/26/1995WO1995013797A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
05/26/1995CA2176934A1 Method for inhibiting angiogenesis using heparinase
05/26/1995CA2176735A1 Non-peptide tachykinin receptor antagonists
05/26/1995CA2176727A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
05/26/1995CA2176507A1 Endothelin-converting enzyme
05/26/1995CA2176220A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
05/26/1995CA2176143A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995CA2175386A1 Diaminocyclobutene-3,4-diones as smooth muscle relaxants
05/26/1995CA2175350A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
05/26/1995CA2174650A1 Piperidinyl camphorsulfonyl oxytocin antagonists
05/24/1995EP0654266A1 Cardiac protective
05/24/1995EP0654077A1 Method and reagent for treatment of animal diseases
05/24/1995EP0654033A1 Asymmetrically substituted xanthine with adenosine-antagonistic properties
05/24/1995EP0654027A1 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists
05/24/1995EP0654024A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
05/24/1995EP0653937A1 Chemical compounds
05/24/1995EP0630275A4 Fibrin sealant delivery method.
05/24/1995CN1028529C Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in treatment of thrombotic and vasospastic disease
05/24/1995CA2136288A1 Imidazopyridazines
05/23/1995US5418249 Renin inhibitors
05/23/1995US5418243 Anticholesterol agents
05/23/1995US5418239 Acylcoenzyme a:cholesterol acyltransferase inhibitors
05/23/1995US5418237 Indole derivatives
05/23/1995US5418235 Hypotensive, Parkinson's disease, schizophrenia
05/23/1995US5418232 Hypotensive, increases renal blood flow
05/23/1995US5418135 Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists
05/23/1995CA1335672C Thioformamide derivatives
05/19/1995CA2134149A1 Compounds containing a fused multiple ring lactam
05/18/1995WO1995013385A2 Thrombin mutants
05/18/1995WO1995013296A1 Receptor specific atrial natriuretic peptides
05/18/1995WO1995013295A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives
05/18/1995WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995WO1995013274A1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives
05/18/1995WO1995013262A1 Substituted phenyl compounds
05/18/1995WO1995013066A1 Pharmaceutical emulsion
05/18/1995WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995WO1995013055A1 Sustained release formulations for 24 hour release of metoprolol
05/18/1995CA2176363A1 Substituted phenyl compounds
05/18/1995CA2176217A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives
05/18/1995CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/17/1995EP0652897A1 Peptide inhibitors of selectin binding
05/17/1995EP0652893A1 Kininogenase inhibitors
05/17/1995EP0652887A1 New derivatives of neuraminic acid
05/17/1995EP0652748A1 A method of increasing creatine supply depot
05/17/1995CN1102649A Piperidines and piperazines
05/17/1995CN1102648A Substituted mono- and bipyridylmethylpyridenes
05/17/1995CN1102645A Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives
05/17/1995CA2135711A1 Cyclic amino acid derivatives
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995US5416111 Cyano-containing n-phenyl-amino-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416105 Treating an arteriosclerosis with glimepiride
05/16/1995US5416104 Oxazolidinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416095 Tetrahydro-quinolinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416094 Antiarrhythmic and cardioprotective substituted -1(2H)isoquinolines, medicament containing them, and their use for combating heart failures
05/16/1995US5416092 3-azabicyclo[3.2.1]-oct-8-yl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416085 3-oxa-8-azabicyclo[3.2.1]oct-8-yl terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416084 Benzo-fused thiomorpholinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/16/1995US5416083 Benzodiazepinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416082 Antiserotonine agents
05/16/1995US5416066 1,4-benzothiazepine derivatives
05/16/1995CA1335594C Piperidinyl imidazole derivatives as antiarrhythmic agents
05/16/1995CA1335592C Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
05/16/1995CA1335577C Superoxide dismutase analogs having novel binding properties
1 ... 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 ... 1595